We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+15.78%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$13.5B
AUM Growth
+$1.89B
Cap. Flow
+$530M
Cap. Flow %
3.93%
Top 10 Hldgs %
31.71%
Holding
339
New
59
Increased
111
Reduced
94
Closed
41

Top Buys

1
META icon
Meta Platforms (Facebook)
META
+$157M
2
JNJ icon
Johnson & Johnson
JNJ
+$155M
3
CHGG icon
Chegg
CHGG
+$87.6M
4
MDT icon
Medtronic
MDT
+$72.1M
5
HUM icon
Humana
HUM
+$69.3M

Top Sells

1
UNH icon
UnitedHealth
UNH
+$133M
2
CIEN icon
Ciena
CIEN
+$99.1M
3
AMD icon
Advanced Micro Devices
AMD
+$79.2M
4
IMMU
Immunomedics Inc
IMMU
+$73.2M
5
AYX
Alteryx Inc
AYX
+$70M

Sector Composition

1 Technology 35.47%
2 Healthcare 19.83%
3 Financials 14.52%
4 Communication Services 13.91%
5 Consumer Discretionary 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
126
Citigroup
C
$217B
$21.1M 0.16%
489,347
+78,253
+19% +$3.9M
USFD icon
127
US Foods
USFD
$21.4B
$19.9M 0.15%
893,370
-338,658
-27% -$7.62M
MO icon
128
Altria Group
MO
$124B
$19.6M 0.15%
507,831
-62,982
-11% -$2.62M
YMAB
129
DELISTED
Y-mAbs Therapeutics
YMAB
$19.4M 0.14%
506,083
– –
GBT
130
DELISTED
Global Blood Therapeutics, Inc.
GBT
$19.3M 0.14%
350,000
+175,000
+100% +$11.1M
ATRC icon
131
AtriCure
ATRC
$1.77B
$19.1M 0.14%
478,119
+94,994
+25% +$4.03M
BMRN icon
132
BioMarin Pharmaceuticals
BMRN
$11.5B
$19M 0.14%
250,000
-255,000
-50% -$25.8M
LLY icon
133
Eli Lilly
LLY
$1.05T
$18.9M 0.14%
+128,000
New +$19.8M
CLDX icon
134
Celldex Therapeutics
CLDX
$2.77B
$18.5M 0.14%
+1,250,000
New +$14.6M
CHNGU
135
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$17.9M 0.13%
335,000
– –
XLRN
136
DELISTED
Acceleron Pharma
XLRN
$17.8M 0.13%
157,762
+59,684
+61% +$5.94M
UNH icon
137
UnitedHealth
UNH
$387B
$17.7M 0.13%
56,672
-432,727
-88% -$133M
SMMT icon
138
Summit Therapeutics
SMMT
$10.7B
$17.2M 0.13%
5,000,000
+500,000
+11% +$1.73M
IQV icon
139
IQVIA
IQV
$34.4B
$16.6M 0.12%
105,293
-316,440
-75% -$49.6M
DG icon
140
Dollar General
DG
$27.7B
$16.4M 0.12%
+78,150
New +$15.4M
ORCL icon
141
Oracle
ORCL
$364B
$16.2M 0.12%
+270,980
New +$15.4M
SGRY icon
142
Surgery Partners
SGRY
$2.09B
$16.1M 0.12%
+736,792
New +$13.1M
KLIC icon
143
Kulicke & Soffa
KLIC
$5.09B
$16.1M 0.12%
719,850
+134,943
+23% +$3.19M
TEL icon
144
TE Connectivity
TEL
$59.3B
$15.8M 0.12%
161,711
+45,869
+40% +$4.22M
BDX icon
145
Becton Dickinson
BDX
$43.6B
$15.6M 0.12%
68,728
-1,333
-2% -$328K
TEAM icon
146
Atlassian
TEAM
$23.7B
$15.4M 0.11%
84,752
+46,759
+123% +$8.34M
KURA icon
147
Kura Oncology
KURA
$964M
$15.3M 0.11%
+500,000
New +$11M
AVDL
148
DELISTED
Avadel Pharmaceuticals
AVDL
$15M 0.11%
2,978,915
– –
AFL icon
149
Aflac
AFL
$63.5B
$14.9M 0.11%
410,000
– –
PRA
150
DELISTED
ProAssurance
PRA
$14.9M 0.11%
950,000
+250,000
+36% +$3.72M
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Polar Capital held 339 positions worth $13.5B, up 16% from $11.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Polar Capital deployed $530M of net new capital in Q3 2020, opening 59 new positions and adding to 111 existing holdings. Its largest new stake was Chegg: 1,189,909 shares worth $85M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $133M trimmed.

  • Polar Capital's largest Q3 2020 buy was Chegg: 1,189,909 shares worth $85M.
  • Polar Capital added most to Meta Platforms (Facebook) in Q3 2020, an estimated $157M increase.
  • Polar Capital's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $133M.
  • Polar Capital fully exited Ciena in Q3 2020, selling an estimated $99.1M.
  • Polar Capital's ten largest holdings make up 32% of its $13.5B portfolio in Q3 2020.
  • Polar Capital opened 59 new positions and closed 41 in Q3 2020.
  • Polar Capital's portfolio value rose 16% quarter-over-quarter to $13.5B.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.